IMMX 8-K 2026-09-30

Immix Biopharma, Inc. (IMMX) 8-K dated 2026-09-30 — accession 0001493152-26-045143. This URL is the filing, not the IMMX hub.

Immix Biopharma, Inc. (IMMX) is a biotechnology company listed on US.

Immix Biopharma, Inc. filed a 8-K on 2026-09-30. Accession 0001493152-26-045143.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IMMX revenue for 2022-12-08 was $20.0M. IMMX currently screens at market cap $640.7M.

Not investment advice. The IMMX SEC hub lists recent forms. The stock page is the research view.